限售股上市

Search documents
精智达: 中信建投证券股份有限公司关于深圳精智达技术股份有限公司首次公开发行部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-07-10 11:12
中信建投证券股份有限公司 关于深圳精智达技术股份有限公司 根据《深圳精智达技术股份有限公司首次公开发行股票并在科创板上市招股 说明书》《深圳精智达技术股份有限公司首次公开发行股票科创板上市公告书》, 本次申请上市流通的首发限售股股东关于其持有的限售股上市流通所作承诺如 下: 首次公开发行部分限售股上市流通的核查意见 中信建投证券股份有限公司(以下简称"中信建投"或"保荐机构")作为 深圳精智达技术股份有限公司(以下简称"精智达"或"公司")首次公开发行 股票并在科创板上市的保荐机构,根据《证券发行上市保荐业务管理办法》《上 海证券交易所科创板股票上市规则》《上海证券交易所首次公开发行证券发行与 承销业务实施细则》等有关法律法规和规范性文件的要求,对精智达首次公开发 行部分限售股上市流通的事项进行了核查,具体情况如下: 一、本次上市流通的限售股类型 中国证券监督管理委员会于2023年5月26日出具了《关于同意深圳精智达技 术股份有限公司首次公开发行股票注册的批复》(证监许可〔2023〕1170号),公 司获准首次向社会公开发行人民币普通股(A股)23,502,939股,并于2023年7月 本次上市流通的限售股为 ...
宝立食品: 国泰海通证券股份有限公司关于上海宝立食品科技股份有限公司首次公开发行部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-07-09 16:25
国泰海通证券股份有限公司(以下简称"保荐机构"、"国泰海通")作为上 海宝立食品科技股份有限公司(以下简称"宝立食品"、"公司")首次公开发行 股票并在主板上市及持续督导的保荐机构,根据《证券发行上市保荐业务管理办 法》《上海证券交易所上市公司自律监管指引第 1 号—规范运作》、《上海证券交 易所上市公司自律监管指引第 11 号—持续督导》等相关法律法规及规范性文件 的规定,对宝立食品首次公开发行部分限售股上市流通的事项进行了核查,核查 情况如下: 一、本次限售股上市类型 经中国证券监督管理委员会《关于核准上海宝立食品科技股份有限公司首次 公开发行股票的批复》(证监许可〔2022〕1308 号)的核准,并经上海证券交 易所同意,公司向社会公众首次公开发行人民币普通股股票(A 股)4,001 万股, 于 2022 年 7 月 15 日在上海证券交易所主板挂牌上市,公司首次公开发行股票 后的总股本为 40,001 万股。 本次上市流通的限售股为首次公开发行限售股,股份持有人为杭州臻品致信 投资合伙企业(有限合伙)(以下简称"臻品致信")、马驹、杭州宝钰投资管理 合伙企业(有限合伙) (以下简称"宝钰投资")及杨雪 ...
皓元医药: 上海皓元医药股份有限公司关于发行股份及支付现金购买资产并募集配套资金暨关联交易之部分限售股上市流通公告
Zheng Quan Zhi Xing· 2025-07-08 09:13
关联交易之部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ? 本次股票上市类型为向特定对象发行股份;股票认购方式为网下,上市股 数为4,493,210股。 本次股票上市流通总数为4,493,210股。 证券代码:688131 证券简称:皓元医药 公告编号:2025-088 转债代码:118051 转债简称:皓元转债 上海皓元医药股份有限公司 关于发行股份及支付现金购买资产并募集配套资金暨 ? 本次股票上市流通日期为2025 年 7 月 16 日。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会(以下简称"中国证监会")于 2022 年 11 月 25 日出具的《关于同意上海皓元医药股份有限公司向 WANG YUAN(王元)等发行 股份购买资产并募集配套资金注册的批复》 (证监许可20223042 号),同意公司向 特定对象 WANG YUAN(王元)、上海源盟企业管理咨询合伙企业(有限合伙) (以 下简称"上海源盟")、宁波九胜创新医药科技有限公司、上海源黎企业管理合伙 企 ...
昊华化工科技集团股份有限公司关于2025年度6月对外担保的进展公告
Shang Hai Zheng Quan Bao· 2025-07-02 18:33
Group 1 - The company announced a guarantee of RMB 14.7 million for its subsidiary Jiangxi Hetian Technology Co., Ltd. [5][11] - As of the announcement date, the total guarantee amount provided by the company to Jiangxi Hetian is RMB 32.35 million [5][11] - The guarantee was approved at the company's 2024 annual general meeting [3][4] Group 2 - The guarantee is backed by Jiaxing Heli Equity Investment Partnership [2] - The guarantee agreement was signed on June 28, 2025, with a guarantee period from June 18, 2025, to June 17, 2026 [10] - The guarantee is intended to support the working capital needs of the subsidiary [11] Group 3 - The company has a total guarantee amount of RMB 1.29 billion, which is 7.37% of the latest audited net assets [13] - The company has no overdue guarantees [4][14] - The company has not provided guarantees to controlling shareholders or related parties [14] Group 4 - The company is set to list 161,290,322 shares for trading on July 8, 2025, as part of a non-public offering [17][18] - The total number of shares after the issuance will be 1,290,033,705 [19] - The issuance was approved by the China Securities Regulatory Commission on June 20, 2024, for a maximum of RMB 4.5 billion [18]
奥比中光: 中国国际金融股份有限公司关于奥比中光首次公开发行部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-06-27 16:10
Core Viewpoint - The report outlines the verification opinion of China International Capital Corporation regarding the listing and circulation of restricted shares from the initial public offering (IPO) of Obsidian Technology Group Co., Ltd. The restricted shares amount to 34,032,240 shares, representing 8.48% of the company's total share capital, and will be available for trading starting July 7, 2025 [1][6][10]. Summary by Sections 1. Type of Restricted Shares - The restricted shares are part of the IPO approved by the China Securities Regulatory Commission on April 22, 2022, with a total of 40,001,000 shares issued. The total share capital after the IPO is 400,001,000 shares, with 7.74% being restricted shares [1][2]. 2. Changes in Share Capital - Since the formation of the restricted shares, the company's total share capital has increased to 400,001,000 shares, with no other changes due to profit distribution or capital reserve transfers [4][5]. 3. Commitments Related to Restricted Shares - The shareholders of the restricted shares have committed not to transfer or manage their shares for three years post-IPO. They can only reduce their holdings by a maximum of 2% of the total shares in the fourth and fifth fiscal years after the IPO [5][10]. 4. Verification of Commitments - As of the date of the verification opinion, the shareholders have strictly adhered to their commitments, and there are no issues affecting the listing of the restricted shares [6][10]. 5. Details of Restricted Shares - The total number of restricted shares to be listed is 34,032,240, which constitutes 8.48% of the total share capital. The listing date for these shares is set for July 7, 2025 [6][8][10].
凌云光: 中国国际金融股份有限公司关于凌云光技术股份有限公司首次公开发行部分限售股上市流通暨承诺不减持事项的核查意见
Zheng Quan Zhi Xing· 2025-06-24 17:01
Core Viewpoint - The report outlines the verification opinion of China International Capital Corporation regarding the listing and circulation of restricted shares of Lingyun Optical Technology Co., Ltd. after its initial public offering, emphasizing compliance with relevant regulations and the commitment of shareholders not to reduce their holdings for a specified period [1][10]. Group 1: Restricted Shares Listing - The restricted shares being listed for circulation total 223,777,585 shares, representing 48.5442% of the company's total share capital [9]. - The listing date for these restricted shares is set for July 7, 2025, as July 6, 2025, is a non-trading day [9]. - The total number of shares issued during the initial public offering was 10,350,000, with a total share capital of 463,500,000 shares post-IPO [1]. Group 2: Changes in Share Capital - Following the repurchase and cancellation of 2,523,267 shares, the company's total share capital decreased from 463,500,000 shares to 460,976,733 shares [2]. - No other events have occurred that would affect the number of shares since the formation of the restricted shares [2]. Group 3: Shareholder Commitments - Shareholders have committed not to transfer or reduce their holdings of restricted shares for 36 months from the date of the IPO [3][4]. - If the share price falls below the IPO price, the lock-up period will automatically extend by at least 6 months [3]. - The controlling shareholders have voluntarily committed not to transfer or reduce their holdings for 12 months following the lifting of the lock-up period on July 7, 2025 [9]. Group 4: Compliance and Verification - The verification opinion confirms that the company has adhered to the relevant laws and regulations regarding the listing of restricted shares [10]. - The report states that the information disclosed by Lingyun Optical regarding the restricted shares is true, accurate, and complete [10].
青云科技: 中国国际金融股份有限公司关于北京青云科技集团股份有限公司首次公开发行部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-06-23 12:16
Core Viewpoint - The report outlines the verification opinion of China International Capital Corporation regarding the listing and circulation of restricted shares for Beijing Qingyun Technology Group Co., Ltd. after its initial public offering on the Sci-Tech Innovation Board [1][10]. Group 1: Listing of Restricted Shares - The restricted shares being listed are part of the company's initial public offering, totaling 11,855,468 shares, which accounts for 24.8024% of the company's total share capital [2][10]. - The shares will be available for circulation starting from July 1, 2025, after a lock-up period of three full accounting years plus an additional six months [2][12]. Group 2: Changes in Share Capital - Following the initial public offering, the company's total share capital increased from 47,462,175 shares to 47,785,987 shares due to the vesting of restricted stock options [2]. - The total share capital will further increase to 47,799,688 shares after the second vesting period of the restricted stock options in 2024 [2]. Group 3: Commitments from Shareholders - Shareholders have committed to not transferring or managing their shares for 36 months post-listing, with specific conditions for reducing their holdings thereafter [3][6]. - The commitments include conditions on share price and operational status of the company, ensuring that any reduction in holdings does not significantly disrupt the market [7][9]. Group 4: Compliance and Verification - The verification opinion confirms that the listing of restricted shares complies with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [10]. - The report indicates that all shareholders have adhered to their commitments, and there are no issues affecting the listing of the restricted shares [10].
中无人机: 中无人机首次公开发行部分限售股上市流通公告
Zheng Quan Zhi Xing· 2025-06-20 13:26
Core Viewpoint - The announcement details the upcoming listing and circulation of restricted shares for AVIC Chengdu UAV Systems Co., Ltd., with a total of 403,378,057 shares set to be released on June 30, 2025, marking a significant event in the company's stock market activity [1][9]. Summary by Sections 1. Listing of Restricted Shares - The shares being listed are part of the company's initial public offering (IPO) and involve 8 shareholders, representing 59.76% of the total share capital [2][10]. - The total number of shares after the IPO is 675,000,000, with 121,794,229 shares being unrestricted and 553,205,771 shares being restricted [1][2]. 2. Changes in Share Capital - Since the formation of the restricted shares, there have been no changes in the company's share capital due to profit distribution or capital reserve transfers [2]. 3. Commitments Related to Restricted Shares - Shareholders and the actual controller, AVIC, have committed not to transfer or manage the shares for 36 months from the date of listing [2][3]. - If the stock price falls below the issue price for 20 consecutive trading days within the first 6 months, the lock-up period will automatically extend by 6 months [3][4]. 4. Compliance and Verification - As of the announcement date, the shareholders have adhered to their commitments, ensuring no issues that would affect the listing of the restricted shares [9]. - The underwriting institutions, CITIC Securities and AVIC Securities, have confirmed that the listing complies with relevant regulations and commitments [9][10]. 5. Details of Restricted Shares - The total number of restricted shares being listed is 403,378,057, which will transition from restricted to unrestricted status on the specified date [10]. - The breakdown of shareholders holding these restricted shares includes various entities under AVIC, ensuring a concentrated ownership structure [10].
春立医疗: 华泰联合证券有限责任公司关于北京市春立正达医疗器械股份有限公司首次公开发行部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-06-19 10:01
Core Viewpoint - The report from Huatai United Securities provides a thorough review of the listing and circulation of restricted shares for Beijing Chunli Zhengda Medical Devices Co., Ltd., confirming compliance with relevant regulations and the fulfillment of commitments by shareholders [1][8]. Group 1: Restricted Shares Overview - The restricted shares being listed for circulation are part of the company's initial public offering, involving two shareholders: Mr. Shi Chunbao and Ms. Yue Shujun. The original lock-up period of 36 months has been extended by 6 months due to the fulfillment of commitment conditions, now set to end on June 30, 2025 [2][6]. - The total number of restricted shares being released is 209,133,335, which accounts for 54.52% of the company's total share capital [6][8]. Group 2: Changes in Share Capital - The company's total share capital has changed from 384,280,000 shares to 383,568,500 shares since the formation of the restricted shares [2][4]. Group 3: Shareholder Commitments - Shareholders have made several commitments regarding their restricted shares, including not proposing buybacks and extending the lock-up period if the stock price falls below the IPO price for a specified duration [4][5]. - As of the date of the announcement, the shareholders have adhered to their commitments, ensuring no issues affecting the listing of restricted shares [5][8]. Group 4: Regulatory Compliance - Huatai United Securities has confirmed that the listing and circulation of the restricted shares comply with various regulatory frameworks, including the Securities Issuance and Listing Sponsorship Business Management Measures and the Shanghai Stock Exchange's rules [1][8].
京城股份: 京城股份发行股份及支付现金购买资产并募集配套资金之部分限售股上市流通的公告
Zheng Quan Zhi Xing· 2025-06-17 11:11
Core Points - The announcement details the listing of restricted shares for Beijing Jingcheng Machinery Electric Company Limited, with a total of 7,034,552 shares set to be publicly traded starting June 24, 2025 [1][5][21] - The shares are part of a non-public issuance related to the acquisition of assets and the raising of supporting funds, approved by the China Securities Regulatory Commission [1][2] - The total number of restricted shares issued for asset acquisition amounts to 46,481,314 shares, with specific lock-up periods for different shareholders [2][3] Share Registration and Lock-up Arrangements - The newly issued shares are subject to a 12-month lock-up period for certain shareholders, after which they will be released in stages based on performance compensation agreements [2][8] - The first phase of unlocking allows for 40% of the shares to be released after the 12-month period, contingent on fulfilling performance obligations for 2021 [2][10] - Subsequent phases will release 20% of shares based on the completion of performance obligations for 2022 and 2023 [2][10] Changes in Share Capital - Following the completion of the non-public issuance, the total share capital of the company increased from 485,000,000 shares to 531,481,314 shares, with 109,481,314 shares classified as restricted [4][6] - The company’s total share capital as of the announcement date is 547,665,988 shares, with 19,469,105 shares under restricted conditions [7][8] Compliance and Verification - The independent financial advisor, CITIC Securities, confirmed that the listing of restricted shares complies with relevant laws and regulations, and that there are no violations affecting the listing [21] - The company has committed to adhering to all regulatory requirements and ensuring the independence of its operations post-transaction [16][19]